Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
1994
Medicaid reimbursement allegations
The company faced allegations that it had intentionally falsified and inflated Medicaid reimbursement claims. Arbor paid $7 million to the government to settle the allegations; the available historical account states that the associated criminal and civil charges were later dropped.
1993
Blue Cross and Blue Shield overcharging allegations
Arbor Drugs was accused of overcharging the Blue Cross and Blue Shield Association by at least $17 million for prescriptions dating from 1988. The dispute was resolved in an out-of-court settlement reported at $15 million.